Class-Level Comparison
Growth Hormone vs Longevity & Anti-Aging Peptides
How the growth hormone and longevity & anti-aging peptide classes differ in mechanism, regulatory status, evidence depth, and the compounds that belong to each.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
Growth Hormone
Growth hormone secretagogues and releasing peptides
Compounds in this class
Longevity & Anti-Aging
Peptides studied for cellular health and aging-related processes
Compounds in this class
Class comparison at a glance
| Attribute | Growth Hormone | Longevity & Anti-Aging |
|---|---|---|
| Compounds | 5 | 8 |
| Total studies indexed | 219 | 615 |
| Human studies | 74 | 84 |
| FDA approved | 2 | 1 |
| In clinical trials | 0 | 0 |
| Research-only | 1 | 5 |
| Category 2 banned | 2 | 2 |
| Average evidence level | L3.8 | L3 |
| Dominant mechanisms | ||
| Administration routes | oral, subcutaneous | intravenous, oral, subcutaneous, sublingual, topical |
When each class is most relevant
Growth Hormone
Growth hormone secretagogues and releasing peptides
- Contains FDA-approved options with regulatory record
- Average evidence tier L3.8 across the class
- 2 compounds restricted from compounding (FDA Category 2)
Longevity & Anti-Aging
Peptides studied for cellular health and aging-related processes
- Contains FDA-approved option with regulatory record
- Average evidence tier L3 across the class
- 2 compounds restricted from compounding (FDA Category 2)
Frequently asked
What is the difference between growth hormone and longevity & anti-aging peptides?
Growth Hormone peptides — growth hormone secretagogues and releasing peptides — most commonly act through ghrh receptor agonism or ghrelin receptor agonism. Longevity & Anti-Aging peptides — peptides studied for cellular health and aging-related processes — most commonly act through ghrh receptor agonism or ghrelin receptor agonism or copper-dependent gene modulation. Beyond mechanism, the classes differ in FDA approval mix (2 approved in growth hormone vs 1 in longevity & anti-aging) and in the depth of human clinical evidence available.
Which class has more FDA-approved compounds?
The growth hormone class currently includes 2 FDA-approved compound(s) out of 5 tracked. The longevity & anti-aging class includes 1 FDA-approved compound(s) out of 8 tracked. FDA status matters because it governs legal availability through compounding pharmacies versus prescription-only dispensing.
Which class has more clinical research?
Growth Hormone compounds collectively account for 219 indexed studies, with 74 involving human subjects. Longevity & Anti-Aging compounds account for 615 indexed studies, 84 human. More studies does not always mean stronger evidence — the quality and design of those studies matters more than raw count.
Can growth hormone and longevity & anti-aging peptides be combined?
Combination protocols across these classes exist in clinical literature and integrative medicine practice, but most evidence for combination safety is weaker than for either class alone. Any stacking decision should involve a qualified clinician familiar with both classes' pharmacology, drug interactions, and overlapping adverse-event profiles.
How do I choose between growth hormone and longevity & anti-aging?
The choice is driven by the therapeutic goal. Growth Hormone is most appropriate when growth hormone secretagogues and releasing peptides. Longevity & Anti-Aging is most appropriate when studied for cellular health and aging-related processes. A qualified clinician can evaluate which class aligns best with your medical history, goals, and regulatory context.
Related class comparisons
Class hub
Growth Hormone →
Class hub
Longevity & Anti-Aging →